Team:UC Davis/Safety
From 2012.igem.org
(Difference between revisions)
Line 80: | Line 80: | ||
<link rel="stylesheet" type="text/css" href="https://2012.igem.org/forum/forum_styles.css" /> | <link rel="stylesheet" type="text/css" href="https://2012.igem.org/forum/forum_styles.css" /> | ||
<script type="text/javascript" src ="https://2012.igem.org/forum/forum_scripts.js"></script> | <script type="text/javascript" src ="https://2012.igem.org/forum/forum_scripts.js"></script> | ||
+ | <script type="text/javascript"> | ||
+ | $(document).ready(function(){ | ||
+ | $('.ntabs a').click(function() { | ||
+ | $this = $(this); | ||
+ | $('.npanel').hide(); | ||
+ | $('.ntabs a.active').removeClass('active'); | ||
+ | $this.addClass('active').blur(); | ||
+ | var contents = $this.attr('href'); | ||
+ | $(contents).fadeIn(250); | ||
+ | return false; | ||
+ | }); | ||
+ | $('.ntabs li:first a').click(); | ||
+ | }); | ||
+ | $(document).ready(function(){ | ||
+ | $("#firstpane p.menu_head").click(function() | ||
+ | { | ||
+ | $(this).css({backgroundImage:"url(./arrow_down.png)"}).next("div.menu_body").slideToggle(300).siblings("div.menu_body").slideUp("slow"); | ||
+ | $(this).siblings().css({backgroundImage:"url(./arrow_right.png)"}); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
<style type="text/css"> | <style type="text/css"> | ||
<!-- beginning of slider style --> | <!-- beginning of slider style --> | ||
Line 121: | Line 142: | ||
h1{border:none; width: 100%; clear: both;} | h1{border:none; width: 100%; clear: both;} | ||
<!-- end of slides style --> | <!-- end of slides style --> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
#globalWrapper { | #globalWrapper { | ||
position: relative; | position: relative; | ||
font-size: 127%; | font-size: 127%; | ||
- | width: 100%; | + | width: 850px //100%; |
margin: 0; | margin: 0; | ||
padding: 0; | padding: 0; | ||
padding-bottom: 10px; | padding-bottom: 10px; | ||
- | + | # background:url(http://img.photobucket.com/albums/v26/bluemelon/bg-2-1.jpg); | |
- | + | # background-repeat: no-repeat; | |
- | + | # background-attachment: fixed; | |
+ | # background-size:100% auto; | ||
} | } | ||
Line 149: | Line 161: | ||
margin: 0 auto; | margin: 0 auto; | ||
padding: 5px 5px 5px 5px;; | padding: 5px 5px 5px 5px;; | ||
- | background: | + | background: transparent; |
color: black; | color: black; | ||
- | + | # border-left: 1px solid #ffffff; | |
- | + | # border-right: 1px solid #ffffff; | |
- | + | # line-height: 1.5em; | |
- | + | ||
} | } | ||
+ | |||
+ | |||
+ | body { | ||
+ | background-color: rgba(255,255,255,1); | ||
+ | background-image: url('http://img.photobucket.com/albums/v26/bluemelon/bg-2-1.jpg'); | ||
+ | background-size: 100%; | ||
+ | background-repeat: no-repeat; | ||
+ | background-attachment:fixed; | ||
+ | |||
+ | color: black; | ||
+ | font: x-small sans-serif; | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | # height:100%; | ||
+ | } | ||
+ | |||
#topmenubar { | #topmenubar { | ||
Line 220: | Line 247: | ||
overflow:hidden; | overflow:hidden; | ||
padding:0px; | padding:0px; | ||
- | margin: | + | margin:2px solid transparent; |
list-style-type:none; | list-style-type:none; | ||
height:24px; | height:24px; | ||
list-style-image:none; | list-style-image:none; | ||
- | background:#004b85; | + | background: #004b85; |
} | } | ||
#newnavi .newmenu li { | #newnavi .newmenu li { | ||
Line 230: | Line 257: | ||
height:24px; | height:24px; | ||
width: 103px; | width: 103px; | ||
- | background:#004b85; | + | background: #004b85; |
- | + | # margin-left: solid 2px transparent; | |
- | + | # margin-right: solid 2px transparent; | |
+ | # margin-bottom: solid 1px transparent; | ||
+ | # border-right: 4px solid #eaf0f2; | ||
+ | # border-left: 2px solid #eaf0f2; | ||
+ | border-right: 2px solid transparent; | ||
+ | border-left: 2px solid transparent; | ||
+ | text-align:center; | ||
} | } | ||
#newnavi .newmenu .selected { | #newnavi .newmenu .selected { | ||
Line 250: | Line 283: | ||
} | } | ||
#newnavi .newmenu li:hover ul { | #newnavi .newmenu li:hover ul { | ||
- | left:0px; top:23px; background:lavender; width:103px; opacity:0.7; z-index: | + | left:0px; top:23px; background:lavender; width:103px; opacity:0.7; z-index:4; |
} | } | ||
#newnavi .newmenu li:hover ul li { | #newnavi .newmenu li:hover ul li { | ||
Line 264: | Line 297: | ||
height:18px; background:silver; color:#000; border:solid 0px #444; | height:18px; background:silver; color:#000; border:solid 0px #444; | ||
} | } | ||
+ | /* slide starts here */ | ||
+ | #slides { | ||
+ | position:relative; | ||
+ | height:350px; | ||
+ | width: 840px | ||
+ | |||
+ | } | ||
+ | |||
+ | #slides IMG { | ||
+ | position:absolute; | ||
+ | opacity:0.0; | ||
+ | top:0px; | ||
+ | left:0px; | ||
+ | z-index:1; | ||
+ | } | ||
+ | |||
+ | #slides .current { | ||
+ | z-index:3; | ||
+ | opacity:1.0; | ||
+ | } | ||
+ | |||
+ | #slides .previous { | ||
+ | z-index:2; | ||
+ | } | ||
+ | /* slide ends here */ | ||
+ | //leftbox, rightbox starts here | ||
+ | |||
+ | #myleftbox | ||
+ | { | ||
+ | position:relative; | ||
+ | width:625px; | ||
+ | float:left; | ||
+ | background-color:#d2d2d2; | ||
+ | margin-top: 0px; | ||
+ | border-radius: 4px; | ||
+ | padding: 0px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: white; | ||
+ | } | ||
+ | #myleftbox .smallbox | ||
+ | { | ||
+ | width:595px; | ||
+ | float:left; | ||
+ | background-color:#bfbfbf; | ||
+ | margin-top: 17px; | ||
+ | margin-bottom: 10px; | ||
+ | border-radius: 4px; | ||
+ | padding: 15px 15px 15px 15px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | line-height:1.5em; | ||
+ | color:black; | ||
+ | } | ||
+ | #myleftbox .smallbox h1 | ||
+ | { | ||
+ | color:#004b85; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | #myleftbox .smallbox p | ||
+ | { | ||
+ | color: #004b85; | ||
+ | font-weight:bold; | ||
+ | } | ||
+ | |||
+ | #myleftbox .threeboxes | ||
+ | { | ||
+ | width:175px; | ||
+ | float:left; | ||
+ | background-color:rgba(143,143,143,0.7); | ||
+ | margin-top: 17px; | ||
+ | border-radius: 4px; | ||
+ | border-left:2px solid #e8eff1; | ||
+ | border-right:2px solid #e8eff1; | ||
+ | padding: 15px 15px 15px 15px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: white; | ||
+ | |||
+ | } | ||
+ | |||
+ | #myleftbox .threeleft | ||
+ | { | ||
+ | width:175px; | ||
+ | float:left; | ||
+ | background-color:#ba9108; | ||
+ | margin-top: 17px; | ||
+ | border-radius: 4px; | ||
+ | padding: 15px 15px 15px 15px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: white; | ||
+ | } | ||
+ | |||
+ | #myleftbox .threecenter | ||
+ | { | ||
+ | width:175px; | ||
+ | #float:left; | ||
+ | background-color:#ba9108; | ||
+ | margin-top: 17px; | ||
+ | border-radius: 4px; | ||
+ | padding: 15px 15px 15px 15px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: white; | ||
+ | } | ||
+ | #myleftbox .threeright | ||
+ | { | ||
+ | width:175px; | ||
+ | float:right; | ||
+ | background-color:#ba9108; | ||
+ | margin-top: 17px; | ||
+ | border-radius: 4px; | ||
+ | padding: 15px 15px 15px 15px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: white; | ||
+ | } | ||
+ | |||
+ | #sponsorbox | ||
+ | { | ||
+ | position: relative; | ||
+ | width: 215px; | ||
+ | margin-top:17px; | ||
+ | float: right; | ||
+ | height: auto; | ||
+ | } | ||
+ | |||
+ | #sponsorbox .sponsorfloat | ||
+ | { | ||
+ | width:205px; | ||
+ | float: right; | ||
+ | background-color: #004b85; | ||
+ | margin-top: 0px; | ||
+ | margin-bottom:5px; | ||
+ | border-radius: 4px; | ||
+ | padding: 5px 5px 5px 5px; | ||
+ | font: sans-serif; | ||
+ | font-size: 13px; | ||
+ | color: rgba(225,225,225,1); | ||
+ | } | ||
+ | |||
+ | #sponsorbox .sponsorfloat h2 | ||
+ | { | ||
+ | #color:#ba9108; | ||
+ | color:white; | ||
+ | font-size:130%; | ||
+ | } | ||
+ | //leftbox, rightbox ends here | ||
+ | |||
+ | #sponsorbox .sponsorfloat a | ||
+ | { | ||
+ | color:white; | ||
+ | } | ||
+ | .newsAnnouncement | ||
+ | { | ||
+ | width:205px; | ||
+ | height:110px; | ||
+ | overflow-x:hidden; | ||
+ | overflow-y:scroll; | ||
+ | } | ||
+ | <!-- notebook tab style starts here --> | ||
+ | .ntabs { | ||
+ | margin: 0; | ||
+ | padding: 0; | ||
+ | zoom : 1; | ||
+ | } | ||
+ | .ntabs li { | ||
+ | float: left; | ||
+ | list-style: none; | ||
+ | padding: 0; | ||
+ | margin: 0; | ||
+ | } | ||
+ | .ntabs a { | ||
+ | display: block; | ||
+ | text-decoration: none; | ||
+ | padding: 1px 8px 1px 8px; | ||
+ | background-color: #ba9108; | ||
+ | margin-right:1px; | ||
+ | border: 1px solid rgb(153,153,153); | ||
+ | border-radius: 4px 4px 0px 0px; | ||
+ | margin-bottom: -1px; | ||
+ | font-size:14px; | ||
+ | line-height:25px; | ||
+ | } | ||
+ | .ntabs a.active { | ||
+ | border-bottom: 1px solid #fdf2b2; | ||
+ | background-color: #fdf2b2; | ||
+ | color: #004b85; | ||
+ | position: relative; | ||
+ | } | ||
+ | .ntabs a:hover { | ||
+ | background-color: rgba(186,145,8,0.3); | ||
+ | } | ||
+ | .npanelContainer { | ||
+ | background:url("./notepad_pattern.jpg") repeat; | ||
+ | clear: both; | ||
+ | margin-bottom: 25px; | ||
+ | border: 1px solid rgb(153,153,153); | ||
+ | background-color: white; | ||
+ | padding: 17px 0 0 10px;; | ||
+ | font-size:14px; | ||
+ | line-height:25px; | ||
+ | border-radius:4px; | ||
+ | } | ||
+ | |||
+ | .npanel h2 { | ||
+ | color: rgb(57,78,121); | ||
+ | text-shadow: none; | ||
+ | } | ||
+ | .npanel p { | ||
+ | color: black; | ||
+ | } | ||
+ | <!-- notebook tab style ends here --> | ||
+ | #firstpane { | ||
+ | position:relative; | ||
+ | } | ||
+ | #firstpane p { | ||
+ | display:block; | ||
+ | } | ||
+ | #firstpane .menu_head { | ||
+ | padding: 5px 20px; | ||
+ | cursor: pointer; | ||
+ | position: relative; | ||
+ | margin:1px; | ||
+ | font-weight:bold; | ||
+ | background: #eef4d3 url(./arrow_right.png) center left no-repeat; | ||
+ | background-position: 5px center; | ||
+ | background-size: 0.7em auto; | ||
+ | } | ||
+ | |||
+ | #firstpane .menu_body { | ||
+ | display:none; | ||
+ | background-color:#e1e1e1; | ||
+ | background-image:none !important; | ||
+ | margin-top:-5px | ||
+ | border-radius:4px; | ||
+ | padding:10px; | ||
+ | } | ||
+ | #firstpane .menu_body a { | ||
+ | display:block; | ||
+ | color:#006699; | ||
+ | background-color:#EFEFEF; | ||
+ | padding-left:10px; | ||
+ | font-weight:bold; | ||
+ | text-decoration:none; | ||
+ | } | ||
+ | #firstpane .menu_body a:hover { | ||
+ | color: #000000; | ||
+ | text-decoration:underline; | ||
+ | } | ||
+ | |||
.floatbox3 | .floatbox3 | ||
Line 283: | Line 568: | ||
font-weight:bold; | font-weight:bold; | ||
font-size: 40px; | font-size: 40px; | ||
- | color: # | + | color: #016D8B;; |
left:10px; | left:10px; | ||
} | } | ||
Line 338: | Line 623: | ||
<li class='new'><a href="https://2012.igem.org/wiki/index.php?title=Talk:Team:UC_Davis&action=edit&redlink=1">Discussion</a></li> | <li class='new'><a href="https://2012.igem.org/wiki/index.php?title=Talk:Team:UC_Davis&action=edit&redlink=1">Discussion</a></li> | ||
- | <li><a href="https://2012.igem.org/wiki/index.php?title=Team:UC_Davis | + | <li><a href="https://2012.igem.org/wiki/index.php?title=Team:UC_Davis&action=edit">Edit</a></li> |
<li><a href="https://2012.igem.org/wiki/index.php?title=Team:UC_Davis&action=history">History</a></li> | <li><a href="https://2012.igem.org/wiki/index.php?title=Team:UC_Davis&action=history">History</a></li> | ||
<li><a href="https://2012.igem.org/Special:MovePage/Team:UC_Davis">Move</a></li> | <li><a href="https://2012.igem.org/Special:MovePage/Team:UC_Davis">Move</a></li> | ||
Line 361: | Line 646: | ||
<li ><a href="https://2012.igem.org/Team:UC_Davis/Notebook" title="Notebook">Notebook</a> | <li ><a href="https://2012.igem.org/Team:UC_Davis/Notebook" title="Notebook">Notebook</a> | ||
<ul> | <ul> | ||
- | <li ><a href="./Notebook.htm ">Week 1</a></li> | + | <li ><a href="https://2012.igem.org/Team:UC_Davis/Notebook/Protocols ">Protocols</a></li> |
- | <li ><a href=" | + | <li ><a href="Notebook.htm ">Week 1</a></li> |
- | <li ><a href=" | + | <li ><a href="Notebook.htm ">Week 2</a></li> |
+ | <li ><a href="Notebook.htm ">Week 3</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
- | <li class="selected"><a href="https://2012.igem.org/Team:UC_Davis/Safety" title="Safety">Safety</a></li> | + | <li class="selected"><a href="https://2012.igem.org/Team:UC_Davis/Safety" title="Safety">Safety</a></li> |
<li ><a href="https://2012.igem.org/Team:UC_Davis/Project" title="Project">Project</a> | <li ><a href="https://2012.igem.org/Team:UC_Davis/Project" title="Project">Project</a> | ||
Line 373: | Line 659: | ||
<li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Strain">Strain</a></li> | <li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Strain">Strain</a></li> | ||
<li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Catalyst">Catalyst</a></li> | <li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Catalyst">Catalyst</a></li> | ||
- | <li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Protein_Engineering">Protein Engineering</a></li> | + | <li ><a href="https://2012.igem.org/Team:UC_Davis/Project/Protein_Engineering" style="font-size:8pt">Protein Engineering</a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
Line 380: | Line 666: | ||
</ul> | </ul> | ||
</div> | </div> | ||
- | + | <!--we extend the main-content div further by removing </div> or if you want to stop here then put </div> back here --> | |
- | + | <img src="http://img.photobucket.com/albums/v26/bluemelon/safety_banner1.jpg" width="850" height="214"> | |
- | <img src="http://img.photobucket.com/albums/v26/bluemelon/safety_banner1.jpg" width="850" height=" | + | |
- | + | <div id="bodyContent"> | |
- | + | <!-- <div id="contentSub"></div> --> | |
+ | <!-- </div> --> | ||
+ | <!-- float: right; first try --> | ||
+ | <!-- <div id="sponsorbox" style="width:220px; float:right;"> --> | ||
- | < | + | <div id="sponsorbox"> |
+ | <div id="sponsorbox" class="sponsorfloat"> | ||
+ | <center> | ||
+ | <h2>News</h2> | ||
+ | </center> | ||
+ | <div class="newsAnnouncement"> | ||
+ | <ul> | ||
+ | <li>Presented our respective project at the UC San Francisco campus. We interacted with teams from UC Berkeley, UCSF, and Stanford-Brown. </li> | ||
+ | <li>Requested the protocal from the iGEM Washington 2011 team, July 10th. </li> | ||
+ | <li>Field trip to Yolo County Landfill, June 27th. Met with Ramin Yazdani, the senior civil engineer at the landfill. </li> | ||
+ | <li>Sushi buffet for lunch, June 21st</li> | ||
+ | <li>First day of iGEM meeting, June 18th</li> | ||
+ | </ul> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div id="sponsorbox" class="sponsorfloat"> | ||
+ | <center> | ||
+ | <h2>Criteria</h2> | ||
+ | View our judging criteria for iGEM 2012 <a href="https://2012.igem.org/Team:UC_Davis/Criteria" style="color:#33FF33;">here</a>. | ||
+ | </center> | ||
+ | </div> | ||
+ | |||
+ | <div id="sponsorbox" class="sponsorfloat"> | ||
+ | <center> | ||
+ | <h2>Our Sponsors</h2> | ||
+ | <a href="http://www.novozymes.com/en/Pages/default.aspx" target="_blank"><img src="https://static.igem.org/mediawiki/2011/2/21/UCD_Novozymes-logo.jpg" width="200"></a> | ||
+ | </center> | ||
+ | |||
+ | <center> | ||
+ | <a href="http://engineering.ucdavis.edu/" target="_blank"><img src="https://static.igem.org/mediawiki/2011/f/f6/UCD_CoE.png" width="200" height="40"></a> | ||
+ | </center> | ||
+ | |||
+ | <center> | ||
+ | <a href="http://biosci.ucdavis.edu/index_js.html" target="_blank"><img src="https://static.igem.org/mediawiki/2011/b/b1/UCD_biosci_sponsor.jpg" width="200" height="90"></a> | ||
+ | </center> | ||
+ | |||
+ | <center> | ||
+ | <a href="http://www.genomecenter.ucdavis.edu/" target="_blank"><img src="https://static.igem.org/mediawiki/2011/1/1b/UCD_Genome_center_sponsor.jpg" width="200" height="60"></a> | ||
+ | </center> | ||
+ | |||
+ | <center> | ||
+ | <a href="http://www.fishersci.com" target="_blank"><img src="https://static.igem.org/mediawiki/2011/a/a4/UCD_Fisher_Logo.gif" width="200"></a> | ||
+ | </center> | ||
+ | |||
+ | <center> | ||
+ | <a href="http://www.bme.ucdavis.edu/" target="_blank"><img src="https://static.igem.org/mediawiki/2011/4/40/UCD_BME_logo_minimal_copy.png" width="200 height="70"></a> | ||
+ | </center> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | <!-- | ||
+ | <a href="https://2011.igem.org/Team:UC_Davis/PartFamilies"><div id="sponsorbox" class="sponsorfloat"></a> | ||
+ | <center> | ||
+ | <h2>Start a Family</h2> | ||
+ | Got a favorite BioBrick? Check our our <a href="https://2011.igem.org/Team:UC_Davis/PartFamilies">process</a> for expanding basic parts into part families. | ||
+ | </div> | ||
+ | --> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | <div id="myleftbox"> | ||
+ | <div id="myleftbox" class="smallbox"> | ||
+ | <!-- Safety content starts here --> | ||
- | |||
<h1> Safety </h1> | <h1> Safety </h1> | ||
<article> | <article> | ||
Line 420: | Line 770: | ||
1. <i>Laboratory Biosafety Manual</i>. The World Health Organization. 2004. 3rd edition. | 1. <i>Laboratory Biosafety Manual</i>. The World Health Organization. 2004. 3rd edition. | ||
<br>2. Callura, Jared, Dwyer, Daniel, Isaacs, Farren, Cantor, Charles, Collins, James. “Tracking, tuning, and terminating microbial physiology using synthetic riboregulators”. PNAS vol. 107 no. 36, pp. 15898-15903. Web. 13 July 2010. | <br>2. Callura, Jared, Dwyer, Daniel, Isaacs, Farren, Cantor, Charles, Collins, James. “Tracking, tuning, and terminating microbial physiology using synthetic riboregulators”. PNAS vol. 107 no. 36, pp. 15898-15903. Web. 13 July 2010. | ||
- | <br>3. “Gene Overview”, <i>Imperial College London iGEM Wiki 2011</i>. | + | <br>3. “Gene Overview”, <i>Imperial College London iGEM Wiki 2011</i>. |
- | + | ||
- | + | ||
</article> | </article> | ||
- | + | </div> | |
</div> | </div> | ||
+ | </div> | ||
+ | |||
+ | <!-- </div> --> | ||
<script>if (window.runOnloadHook) runOnloadHook();</script> | <script>if (window.runOnloadHook) runOnloadHook();</script> | ||
</div> | </div> | ||
</div> | </div> | ||
- | |||
</body> | </body> | ||
</html> | </html> |
Revision as of 21:53, 15 August 2012
News
- Presented our respective project at the UC San Francisco campus. We interacted with teams from UC Berkeley, UCSF, and Stanford-Brown.
- Requested the protocal from the iGEM Washington 2011 team, July 10th.
- Field trip to Yolo County Landfill, June 27th. Met with Ramin Yazdani, the senior civil engineer at the landfill.
- Sushi buffet for lunch, June 21st
- First day of iGEM meeting, June 18th
Criteria
View our judging criteria for iGEM 2012 here.Safety
Our team made sure to perform a thorough analysis of safety for all parts of our project, since safety for researchers, the public, and the environment are all important. We work within a Level 2 Biosafety Lab, as defined by the Laboratory Biosafety Manual (1). This facility is well equipped to work with all the strains of E. coli we used. We used MG1655, DH5α, and K12, all of which are Risk Level 1, meaning these strains pose no pathogenic risk to humans, and were completely contained within the lab.
We always made sure to make use of protective gear, such as wearing gloves at all times, masks when using UV lamps, and lab coats when appropriate. All of our waste was autoclaved on site as well, and all tools and glassware thoroughly cleaned after each use.
We worked with ethylene glycol during our experiments, which is toxic to the kidney, liver and central nervous system, as well as a skin and eye irritant. Obviously, we wanted to be very safe when using this chemical, so we made sure to consult with our advisers on how best to handle it. When using ethylene glycol, we always worked under a fume hood and wore lab coats. We had a separate waste bottle for all of the byproducts with ethylene glycol, so that the waste could be treated.
The University of California at Davis has a biosafety group, which heads the disposal and use of hazardous materials. They approve of our project and the procedures that we have followed. Further, they are excited for the potential that this project has, in terms of making the environment safer for inhabitants.
Our BioBricked parts do not raise any safety concerns, as long as the enzymes breaking down ethylene glycol are fully functional.
Our project, when properly functioning, should not have any harmful effect on the environment, researchers, or the public. We keep everything contained within the lab, and all of the plates and wastes are autoclaved to prevent all bacteria we use from spreading to the outside environment. If we were to escalate our project to an industrial level, everything would still be contained within the facility.
If we were to implement our bacteria in a landfill, chances are it could not survive past a couple generations and therefore would not be very toxic. However, if we were to imagine a more robust version of our strain created in the future, we would implement a kill switch, which has already been created using synthetic biology, to make sure we could stop it (2). We would also create a system similar to Imperial College London’s Gene Guard, which would stop to plastic-degrading plasmid from getting transferred to other bacteria (3). This would contain the plasmid within only our bacteria, so it would not get out of hand.
Our project could potentially be dangerous if our strain received a pathogenic plasmid by lateral gene transfer from other organisms. However, if this were a concern, our strain would be just a susceptible to pathogenicity as any other. If someone with malicious intent were to use our construct, perhaps the most they could do is release it into the water way and have it degrade plastic pipes made of PET, or modify it to degrade other plastics in addition to PET and degrade something useful. Cutinase, the first enzyme in our degradation pathway, functions optimally at 50° C, and the water in our pipes would most likely not be at that temperature. Also, it is unlikely the strain would survive under conditions such as this temperature and being in an aquatic environment.
1. Laboratory Biosafety Manual. The World Health Organization. 2004. 3rd edition.
2. Callura, Jared, Dwyer, Daniel, Isaacs, Farren, Cantor, Charles, Collins, James. “Tracking, tuning, and terminating microbial physiology using synthetic riboregulators”. PNAS vol. 107 no. 36, pp. 15898-15903. Web. 13 July 2010.
3. “Gene Overview”, Imperial College London iGEM Wiki 2011.